-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Upstream Bio, Lowers Price Target to $18

Benzinga·11/11/2026 11:36:03
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield maintains Upstream Bio (NASDAQ:UPB) with a Buy and lowers the price target from $36 to $18.